Two Sigma Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-800
Closed -$295K 1647
2024
Q4
$295K Sell
800
-17,600
-96% -$7.36M 0.04% 661
2024
Q3
$9.57M Buy
18,400
+16,000
+667% +$8.55M 0.16% 159
2024
Q2
$1.3M Sell
2,400
-1,700
-41% -$899K 0.02% 939
2024
Q1
$2.13M Sell
4,100
-8,300
-67% -$4.13M 0.02% 727
2023
Q4
$5.85M Buy
12,400
+5,000
+68% +$2.31M 0.06% 326
2023
Q3
$3.22M Buy
7,400
+500
+7% +$227K 0.03% 507
2023
Q2
$3.07M Buy
6,900
+2,200
+47% +$1.01M 0.05% 438
2023
Q1
$2.16M Buy
4,700
+3,700
+370% +$1.76M 0.04% 488
2022
Q4
$513K Buy
+1,000
New +$508K 0.02% 1069
2022
Q2
Sell
-1,600
Closed -$786K 2378
2022
Q1
$786K Buy
1,600
+1,100
+220% +$503K 0.03% 728
2021
Q4
$232K Sell
500
-2,300
-82% -$968K 0.01% 974
2021
Q3
$1.04M Buy
2,800
+900
+47% +$342K 0.03% 480
2021
Q2
$725K Buy
+1,900
New +$726K 0.02% 502
2021
Q1
Sell
-6,600
Closed -$2.12M 1094
2020
Q4
$2.12M Sell
6,600
-3,100
-32% -$951K 0.05% 233
2020
Q3
$2.6M Sell
9,700
-4,700
-33% -$1.26M 0.05% 167
2020
Q2
$3.79M Buy
14,400
+1,900
+15% +$507K 0.08% 132
2020
Q1
$2.84M Sell
12,500
-24,600
-66% -$6.7M 0.06% 189
2019
Q4
$11.2M Sell
37,100
-26,800
-42% -$7.37M 0.08% 205
2019
Q3
$15.3M Buy
63,900
+14,900
+30% +$4.08M 0.14% 99
2019
Q2
$13.8M Sell
49,000
-400
-0.8% -$109K 0.14% 96
2019
Q1
$14.2M Buy
49,400
+2,600
+6% +$752K 0.13% 72
2018
Q4
$12.3M Sell
46,800
-9,200
-16% -$2.53M 0.15% 70
2018
Q3
$15.3M Sell
56,000
-5,300
-9% -$1.38M 0.1% 134
2018
Q2
$14.6M Sell
61,300
-14,500
-19% -$3.36M 0.07% 204
2018
Q1
$16.7M Buy
75,800
+61,900
+445% +$14.5M 0.09% 186
2017
Q4
$3.13M Buy
+13,900
New +$2.96M 0.08% 178

Other funds holding ELV

Two Sigma Securities's ELV Position: Q1 2026 in Review

Two Sigma Securities reduced its Elevance Health (ELV) stake by 23% in Q1 2026, selling an estimated $136K and leaving 1,367 shares worth $400K. The position accounts for 0.05% of the portfolio, ranked #581.

Two Sigma Securities first reported a position in ELV in Q3 2016 and has held it in 26 quarters since. The position peaked at $2.17M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Two Sigma Securities held 1,367 shares of Elevance Health worth $400K as of Q1 2026.
  • Two Sigma Securities sold 415 Elevance Health shares in Q1 2026, an estimated $136K.
  • Elevance Health made up 0.05% of Two Sigma Securities's portfolio in Q1 2026, its #581 holding.
  • Two Sigma Securities first reported a position in Elevance Health in Q3 2016 and has held it in 26 quarters since.
  • Two Sigma Securities's Elevance Health position peaked at $2.17M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.